Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 59 filers reported holding Y-MABS THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $728,424 | +93.6% | 60,300 | -21.8% | 0.00% | – |
| Q4 2022 | $376,248 | -66.2% | 77,100 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $1,112,000 | -4.7% | 77,100 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,167,000 | +58.3% | 77,100 | +24.4% | 0.00% | – |
| Q1 2022 | $737,000 | -20.7% | 62,000 | +8.2% | 0.00% | -100.0% |
| Q4 2021 | $929,000 | -43.2% | 57,300 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,635,000 | -15.6% | 57,300 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,937,000 | +38.4% | 57,300 | +23.8% | 0.00% | 0.0% |
| Q1 2021 | $1,400,000 | -37.3% | 46,300 | +2.7% | 0.00% | -50.0% |
| Q4 2020 | $2,233,000 | +29.0% | 45,100 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $1,731,000 | -9.7% | 45,100 | +1.6% | 0.00% | -50.0% |
| Q2 2020 | $1,918,000 | +90.8% | 44,400 | +15.3% | 0.00% | +100.0% |
| Q1 2020 | $1,005,000 | -14.0% | 38,500 | +2.9% | 0.00% | 0.0% |
| Q4 2019 | $1,169,000 | +253.2% | 37,400 | +194.5% | 0.00% | – |
| Q3 2019 | $331,000 | +14.1% | 12,700 | 0.0% | 0.00% | – |
| Q2 2019 | $290,000 | – | 12,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 191,176 | $2,757,000 | 9.37% |
| Sofinnova Investments, Inc. | 2,194,278 | $31,641,000 | 1.84% |
| MPM BioImpact LLC | 443,702 | $6,398,000 | 1.52% |
| Artal Group S.A. | 400,000 | $5,768,000 | 0.25% |
| Polar Capital Holdings Plc | 2,531,546 | $36,505,000 | 0.23% |
| ASHFORD CAPITAL MANAGEMENT INC | 101,970 | $1,470,000 | 0.22% |
| Lombard Odier Asset Management (Switzerland) SA | 168,795 | $2,434,000 | 0.21% |
| Soleus Capital Management, L.P. | 87,182 | $1,257,000 | 0.17% |
| Cormorant Asset Management, LP | 150,000 | $2,163,000 | 0.15% |
| Walleye Capital LLC | 437,344 | $6,307,000 | 0.12% |